FERMT1 (Fermitin family homolog 1) variants and mutations
FERMT1 (also known as Fermitin family homolog 1) is a human protein-coding gene encoding a fermitin family homolog 1 protein. It activates integrins and connects them to the actin cytoskeleton in basal keratinocytes, supporting adhesion of epidermis to basement membrane. Biallelic loss-of-function variants cause Kindler epidermolysis bullosa, with skin fragility, photosensitivity, and progressive poikiloderma. This analysis covers 968 FERMT1 variants and mutations. Of these, 77% have computational variant effect predictions. Disease context includes Kindler syndrome, Abnormality of the skeletal system, and benign colon neoplasm. Example FERMT1 variants include S3P, S4F, and S4Y.
Variant analysis overview
- Gene: FERMT1
- Protein: Fermitin family homolog 1
- UniProt accession: Q9BQL6
- Organism: Homo sapiens
- Variants analyzed: 968
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 740 unspecified-consequence records; 1 stop lost; 90 synonymous variants; 103 missense variants; 20 frameshift variants; 2 in-frame deletions; 6 splice-region variants; 3 stop-gained variants; 3 substitution
- Prediction scores: 746 variants have prediction scores (77% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Kindler syndrome, Abnormality of the skeletal system, benign colon neoplasm, hypertensive disorder, atrial fibrillation, colorectal cancer, polyp of colon, colonic neoplasm, response to diuretic, colon carcinoma, Abnormality of the skin, atrial flutter.
Protein structure and variant hotspots
- Protein features: 2 domains; 3 post-translational modification sites.
- Structural context: 810 variants have structural context.
- PTM context: 3 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable FERMT1 variants
Examples include S3P, S4F, S4Y, T8A, F9S, A10V, S11C, W12*. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S3P (p.Ser3Pro), rs758985794, ClinGen CA9758569, ClinVar RCV001991603, ClinVar RCV005565100, REVEL 0.11, CADD 23.40, Uncertain significance, Inborn genetic diseases; not provided
- S4F (p.Ser4Phe), NCI-TCGA Cosmic COSV9945, Variant assessed as somatic; moderate impact.
- S4Y (p.Ser4Tyr), gnomAD rs1242138027, REVEL 0.10, CADD 23.40
- T8A (p.Thr8Ala), rs776284106, ClinGen CA9758568, ClinVar RCV001947397, ExAC rs776284106, REVEL 0.03, CADD 5.05, Uncertain significance, not provided
- F9S (p.Phe9Ser), ExAC rs761144951, gnomAD rs761144951, REVEL 0.14, CADD 16.00
- A10V (p.Ala10Val), TOPMed rs1983207902, REVEL 0.09, CADD 21.50
- S11C (p.Ser11Cys), gnomAD rs1195109466
- W12* (p.Trp12Ter), rs773429449, ClinGen CA9758565, ClinVar RCV003154181, ExAC rs773429449, Pathogenic
- E13* (p.Glu13Ter), TOPMed rs1177117470
- E13K (p.Glu13Lys), rs1177117470, ClinGen CA408195669, ClinVar RCV002833213, REVEL 0.19, CADD 20.60, Uncertain significance, not provided
- L14F (p.Leu14Phe), 1000Genomes rs1983207194, gnomAD rs1983207194, REVEL 0.50, CADD 25.00
- L14P (p.Leu14Pro), TOPMed rs999728597, gnomAD rs999728597, REVEL 0.79, CADD 25.70, Uncertain significance
- L14R (p.Leu14Arg), rs999728597, ClinGen CA408195610, ClinVar RCV002012200, TOPMed rs999728597, REVEL 0.73, CADD 25.40, Uncertain significance, not provided
- L14V (p.Leu14Val), 1000Genomes rs1983207194, gnomAD rs1983207194, REVEL 0.38, CADD 24.50
- V15M (p.Val15Met), gnomAD rs1983206842, REVEL 0.15, CADD 6.67
- V16I (p.Val16Ile), TOPMed rs1193606562, REVEL 0.02, CADD 3.84
- R17C (p.Arg17Cys), rs367672925, ClinGen CA9758562, ClinVar RCV001863785, ESP rs367672925, REVEL 0.14, CADD 22.60, Uncertain significance, not provided
- R17H (p.Arg17His), rs369858160, ClinGen CA9758561, ClinVar RCV002035932, ClinVar RCV003418326, REVEL 0.04, CADD 2.92, Uncertain significance, Inborn genetic diseases; FERMT1-related disorder; not provided
- V18A (p.Val18Ala), TOPMed rs1011251708, gnomAD rs1011251708, REVEL 0.34, CADD 22.10
- V18F (p.Val18Phe), ExAC rs780463226, TOPMed rs780463226, gnomAD rs780463226, Uncertain significance
- V18I (p.Val18Ile), rs780463226, ClinGen CA9758559, ClinVar RCV002520028, ExAC rs780463226, REVEL 0.07, CADD 11.70, Uncertain significance, not provided
- D19G (p.Asp19Gly), rs1372798358, NCI-TCGA Cosmic COSV9945, gnomAD rs1372798358, REVEL 0.29, CADD 19.60, Variant assessed as somatic; moderate impact.
- D19N (p.Asp19Asn), TOPMed rs1983205613, gnomAD rs1983205613, REVEL 0.18, CADD 18.30
- H20Q (p.His20Gln), rs1983205071, ClinGen CA408195436, ClinVar RCV003327989, TOPMed rs1983205071, REVEL 0.06, CADD 7.89, Uncertain significance, not provided
- H20R (p.His20Arg), 1000Genomes rs140624712, ExAC rs140624712, TOPMed rs140624712, gnomAD rs140624712, REVEL 0.10, CADD 12.90
- N22D (p.Asn22Asp), rs201029402, ClinGen CA9758557, ClinVar RCV000322283, ClinVar RCV001861169, REVEL 0.03, CADD 6.68, Uncertain significance, Kindler syndrome; not provided
- N22I (p.Asn22Ile), ESP rs368952038, ExAC rs368952038, TOPMed rs368952038, gnomAD rs368952038, REVEL 0.08, CADD 10.20
- N22S (p.Asn22Ser), ESP rs368952038, ExAC rs368952038, TOPMed rs368952038, gnomAD rs368952038, REVEL 0.02, CADD 0.92, Uncertain significance, Inborn genetic diseases
- E23K (p.Glu23Lys), rs1056137, NCI-TCGA Cosmic COSV5409, Ensembl rs1056137, REVEL 0.07, CADD 4.63, Variant assessed as somatic; moderate impact.
- E24K (p.Glu24Lys), 1000Genomes rs151287434, ExAC rs151287434, gnomAD rs151287434, REVEL 0.04, CADD 13.90
- Q25K (p.Gln25Lys), ExAC rs752585747, gnomAD rs752585747, REVEL 0.05, CADD 1.08
- D28N (p.Asp28Asn), gnomAD rs1237497475, REVEL 0.05, CADD 16.60
- V29I (p.Val29Ile), rs759081971, ClinGen CA9758552, ClinVar RCV001961211, ClinVar RCV002569204, REVEL 0.02, CADD 0.53, Conflicting interpretations, not provided; Inborn genetic diseases
- T30P (p.Thr30Pro), 1000Genomes rs538757728, ExAC rs538757728, gnomAD rs538757728, REVEL 0.24, CADD 22.20
- T30S (p.Thr30Ser), NCI-TCGA Cosmic COSV9945, Variant assessed as somatic; moderate impact.
- L31M (p.Leu31Met), NCI-TCGA Cosmic COSV9945, Variant assessed as somatic; moderate impact.
- R32G (p.Arg32Gly), rs766072646, ClinGen CA9758550, ClinVar RCV002785544, ExAC rs766072646, REVEL 0.33, CADD 16.80, Uncertain significance, not provided
- R32K (p.Arg32Lys), rs760234003, NCI-TCGA Cosmic COSV9945, ExAC rs760234003, gnomAD rs760234003, REVEL 0.22, CADD 15.40, Variant assessed as somatic; moderate impact.
- V33I (p.Val33Ile), gnomAD rs1230189322, REVEL 0.32, CADD 24.40
- S34F (p.Ser34Phe), Ensembl rs1983203164, REVEL 0.18, CADD 24.30
- S34P (p.Ser34Pro), ExAC rs773695393, gnomAD rs773695393, REVEL 0.23, CADD 22.20
- L37F (p.Leu37Phe), ExAC rs762180518, TOPMed rs762180518, gnomAD rs762180518, REVEL 0.26, CADD 23.10
- H38Q (p.His38Gln), 1000Genomes rs10373, ESP rs10373, ExAC rs10373, TOPMed rs10373, Benign
- H38Y (p.His38Tyr), ExAC rs775020997, TOPMed rs775020997, gnomAD rs775020997, REVEL 0.58, CADD 26.20, Uncertain significance, Inborn genetic diseases
- V39F (p.Val39Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V39I (p.Val39Ile), rs749427526, ExAC rs749427526, TOPMed rs749427526, gnomAD rs749427526, REVEL 0.10, CADD 0.05, Variant assessed as somatic; moderate impact.
- G40E (p.Gly40Glu), TOPMed rs1213603254, REVEL 0.64, CADD 24.70
- M43I (p.Met43Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- M43T (p.Met43Thr), TOPMed rs1245430194
- L44H (p.Leu44His), gnomAD rs1162275820, REVEL 0.55, CADD 27.40
- K45Q (p.Lys45Gln), ExAC rs780266799, gnomAD rs780266799, REVEL 0.11, CADD 20.60
- V47A (p.Val47Ala), rs1568667079, ClinGen CA408194840, ClinVar RCV002023340, Ensembl rs1568667079, REVEL 0.60, CADD 28.40, Uncertain significance, not provided
- V47G (p.Val47Gly), Ensembl rs1568667079, Uncertain significance
- V47I (p.Val47Ile), Ensembl rs780902740
- E48G (p.Glu48Gly), TOPMed rs1157852326, gnomAD rs1157852326, REVEL 0.57, CADD 24.90
- Q49E (p.Gln49Glu), TOPMed rs929847047, gnomAD rs929847047, REVEL 0.09, CADD 1.65
- Q49R (p.Gln49Arg), Ensembl rs917679321
- N51D (p.Asn51Asp), gnomAD rs1983200946, REVEL 0.06, CADD 18.60
- N51T (p.Asn51Thr), NCI-TCGA Cosmic COSV5409, Variant assessed as somatic; moderate impact.
- I52T (p.Ile52Thr), ExAC rs771157754, gnomAD rs771157754, REVEL 0.06, CADD 21.60, Uncertain significance, not provided
- I52V (p.Ile52Val), gnomAD rs1296444669, REVEL 0.04, CADD 7.15
- S53P (p.Ser53Pro), ExAC rs747990571, TOPMed rs747990571, gnomAD rs747990571, Uncertain significance
- S53T (p.Ser53Thr), ExAC rs747990571, TOPMed rs747990571, gnomAD rs747990571, REVEL 0.04, CADD 0.05, Uncertain significance, Inborn genetic diseases
- Q54R (p.Gln54Arg), gnomAD rs1320719158, REVEL 0.13, CADD 15.00
- D55H (p.Asp55His), NCI-TCGA Cosmic COSV9945, Variant assessed as somatic; moderate impact.
- W56R (p.Trp56Arg), rs756108637, ClinGen CA9758519, ClinVar RCV001874719, ClinVar RCV002551672, REVEL 0.77, CADD 31.00, Uncertain significance, Inborn genetic diseases; not provided
- D58A (p.Asp58Ala), Ensembl rs1983088063
- A60S (p.Ala60Ser), TOPMed rs1983087863
- A60V (p.Ala60Val), NCI-TCGA Cosmic COSV5409, Variant assessed as somatic; moderate impact.
- L61F (p.Leu61Phe), rs754978561, NCI-TCGA Cosmic COSV5409, NCI-TCGA Cosmic COSV9945, ExAC rs754978561, REVEL 0.15, CADD 23.50, Variant assessed as somatic; moderate impact.
- E64D (p.Glu64Asp), ExAC rs749230193, TOPMed rs749230193, gnomAD rs749230193, REVEL 0.26, CADD 19.50
- E64K (p.Glu64Lys), Ensembl rs2123150767, REVEL 0.39, CADD 24.40
- Q65R (p.Gln65Arg), gnomAD rs1983087393, REVEL 0.12, CADD 25.10
- K66R (p.Lys66Arg), TOPMed rs1286838323, gnomAD rs1286838323, REVEL 0.06, CADD 22.40
- H67Q (p.His67Gln), Ensembl rs1983087208, REVEL 0.02, CADD 1.58
- C68F (p.Cys68Phe), rs2123150728, ClinGen CA408192966, ClinVar RCV002038757, Ensembl rs2123150728, AlphaMissense 0.13, MetaLR 0.04, Uncertain significance, not provided
- W69* (p.Trp69Ter), rs1433586125, NCI-TCGA Cosmic COSV9945, gnomAD rs1433586125, CADD 41.00, Variant assessed as somatic; high impact.
- W69R (p.Trp69Arg), Ensembl rs1983087104, REVEL 0.75, CADD 29.10
- L71P (p.Leu71Pro), TOPMed rs1186917419, gnomAD rs1186917419, REVEL 0.66, CADD 27.90
- T73S (p.Thr73Ser), rs2514723477, ClinGen CA408192885, ClinVar RCV002844215, Uncertain significance, Inborn genetic diseases
- H74L (p.His74Leu), ExAC rs749909572, TOPMed rs749909572
- H74R (p.His74Arg), ExAC rs749909572, TOPMed rs749909572, REVEL 0.14, CADD 18.20
- W75* (p.Trp75Ter), NCI-TCGA Cosmic COSV5409, Ensembl rs1983085952, CADD 41.00, Variant assessed as somatic; high impact.
- T76A (p.Thr76Ala), rs973160821, ClinGen CA311232801, ClinVar RCV002606781, ClinVar RCV005844202, REVEL 0.36, CADD 25.70, Uncertain significance, not provided; Inborn genetic diseases
- T76I (p.Thr76Ile), rs202213120, ClinGen CA311232784, ClinVar RCV001877791, ClinVar RCV005564966, REVEL 0.56, CADD 26.40, Uncertain significance, Inborn genetic diseases; not provided
- T76N (p.Thr76Asn), 1000Genomes rs202213120, ExAC rs202213120, TOPMed rs202213120, gnomAD rs202213120, REVEL 0.45, CADD 25.70, Uncertain significance
- Y80C (p.Tyr80Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G81A (p.Gly81Ala), NCI-TCGA Cosmic COSV5409, TOPMed rs1983084990, Variant assessed as somatic; moderate impact.
- Q83E (p.Gln83Glu), Ensembl rs2123150550
- A84E (p.Ala84Glu), TOPMed rs1983084651
- A84T (p.Ala84Thr), 1000Genomes rs188529776, ExAC rs188529776, gnomAD rs188529776, REVEL 0.39, CADD 26.20
- A84V (p.Ala84Val), TOPMed rs1983084651
- D85E (p.Asp85Glu), rs368160547, ClinGen CA9758506, ClinVar RCV002016376, ESP rs368160547, REVEL 0.29, CADD 10.60, Uncertain significance, not provided
- D85V (p.Asp85Val), ExAC rs776160144, TOPMed rs776160144, gnomAD rs776160144, REVEL 0.48, CADD 27.10
- D85Y (p.Asp85Tyr), Ensembl rs866514305
- A86G (p.Ala86Gly), Ensembl rs1568665692
- K87N (p.Lys87Asn), Ensembl rs201299848, REVEL 0.03, CADD 18.30
- F90L (p.Phe90Leu), ExAC rs568046323, gnomAD rs568046323, REVEL 0.34, CADD 27.70, Uncertain significance, Inborn genetic diseases
- T91A (p.Thr91Ala), gnomAD rs1376290661, REVEL 0.20, CADD 26.50
- T91I (p.Thr91Ile), NCI-TCGA Cosmic COSV9945, Variant assessed as somatic; moderate impact.
- T91P (p.Thr91Pro), gnomAD rs1376290661
- K95R (p.Lys95Arg), TOPMed rs1983083345
- M96I (p.Met96Ile), rs184921922, ClinGen CA9758499, ClinVar RCV002036943, 1000Genomes rs184921922, REVEL 0.03, CADD 16.30, Uncertain significance, not provided
- R98C (p.Arg98Cys), rs141690919, ClinGen CA9758497, ClinVar RCV001910065, ClinVar RCV005397143, REVEL 0.18, CADD 24.50, Uncertain significance, not provided; Kindler syndrome
- R98H (p.Arg98His), rs137862671, ClinGen CA9758496, ClinVar RCV000882780, ClinVar RCV001138874, REVEL 0.22, CADD 25.60, Likely benign, Kindler syndrome; not provided
- R98L (p.Arg98Leu), 1000Genomes rs137862671, ESP rs137862671, ExAC rs137862671, TOPMed rs137862671, REVEL 0.15, CADD 22.30, Likely benign
- R100C (p.Arg100Cys), rs914756695, ClinGen CA311232632, ClinVar RCV002720927, TOPMed rs914756695, REVEL 0.18, CADD 26.80, Uncertain significance, not provided
- R100H (p.Arg100His), rs146184803, ClinGen CA9758494, ClinVar RCV001916272, ESP rs146184803, REVEL 0.15, CADD 24.10, Uncertain significance, not provided
- R100S (p.Arg100Ser), TOPMed rs914756695, gnomAD rs914756695, REVEL 0.08, CADD 24.80, Uncertain significance, in KNDLRS
- R100del, rs869312720, Pathogenic
- P102L (p.Pro102Leu), rs777516456, ClinGen CA9758492, ClinVar RCV001370960, ClinVar RCV004980400, REVEL 0.35, CADD 25.80, Uncertain significance, not provided; Inborn genetic diseases
- N103Y (p.Asn103Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R108K (p.Arg108Lys), 1000Genomes rs201129798, ESP rs201129798, ExAC rs201129798, TOPMed rs201129798, Uncertain significance
- R108T (p.Arg108Thr), rs201129798, ClinGen CA9758490, ClinVar RCV002046831, ClinVar RCV005841849, REVEL 0.15, CADD 21.80, Uncertain significance, not provided; Inborn genetic diseases
- L109M (p.Leu109Met), TOPMed rs1361205005, gnomAD rs1361205005, REVEL 0.08, CADD 1.16
- R110* (p.Arg110Ter), rs765716291, ClinGen CA9758489, NCI-TCGA Cosmic COSV5409, ClinVar RCV001783270, CADD 38.00, Pathogenic
- R110L (p.Arg110Leu), ExAC rs760079665, TOPMed rs760079665, gnomAD rs760079665, Uncertain significance
- R110Q (p.Arg110Gln), rs760079665, ClinGen CA9758488, ClinVar RCV002696720, ClinVar RCV005932196, REVEL 0.14, CADD 25.50, Uncertain significance, Inborn genetic diseases
- S112T (p.Ser112Thr), gnomAD rs1243546070, REVEL 0.12, CADD 21.20
- F113L (p.Phe113Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S114* (p.Ser114Ter), rs1983080839, ClinGen CA408192086, ClinVar RCV001352793, Ensembl rs1983080839, Pathogenic
- V116L (p.Val116Leu), TOPMed rs1188124850, gnomAD rs1188124850, REVEL 0.09, CADD 19.00
- F118V (p.Phe118Val), NCI-TCGA Cosmic COSV9945, Variant assessed as somatic; moderate impact.
- A120T (p.Ala120Thr), rs753934719, ClinGen CA9758487, ClinVar RCV004391817, ExAC rs753934719, REVEL 0.11, CADD 22.10, Uncertain significance, Inborn genetic diseases
- A120V (p.Ala120Val), TOPMed rs1983080542
- V121L (p.Val121Leu), ExAC rs766455399, gnomAD rs766455399, REVEL 0.31, CADD 24.20
- S122G (p.Ser122Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S122I (p.Ser122Ile), gnomAD rs1396098373, REVEL 0.06, CADD 14.70
- D123G (p.Asp123Gly), gnomAD rs1349852986, REVEL 0.18, CADD 24.50
- I124T (p.Ile124Thr), rs760691296, ClinGen CA9758485, ClinVar RCV002009958, ExAC rs760691296, REVEL 0.71, CADD 27.10, Uncertain significance, not provided
- C125AfsX4, rs869312723, Pathogenic
- N129K (p.Asn129Lys), rs1269063125, ClinGen CA408190848, ClinVar RCV002829814, REVEL 0.45, CADD 24.50, Uncertain significance, not provided
- N129S (p.Asn129Ser), Ensembl rs1982985477, REVEL 0.38, CADD 23.10
- R131G (p.Arg131Gly), Ensembl rs1300379789
- R131T (p.Arg131Thr), NCI-TCGA Cosmic COSV5409, Variant assessed as somatic; moderate impact.
- S133L (p.Ser133Leu), NCI-TCGA Cosmic COSV9945, Variant assessed as somatic; moderate impact.
- S137F (p.Ser137Phe), NCI-TCGA Cosmic COSV5409, Variant assessed as somatic; moderate impact.
- L138F (p.Leu138Phe), 1000Genomes rs539867893, ExAC rs539867893, TOPMed rs539867893, gnomAD rs539867893, REVEL 0.60, CADD 19.90, Likely benign
- P141L (p.Pro141Leu), rs369542572, ClinGen CA9758464, ClinVar RCV001898773, ClinVar RCV005564999, REVEL 0.11, CADD 22.90, Uncertain significance, Inborn genetic diseases; not provided
- P141S (p.Pro141Ser), NCI-TCGA Cosmic COSV9945, Variant assessed as somatic; moderate impact.
- G143D (p.Gly143Asp), Ensembl rs1017159941, REVEL 0.05, CADD 15.40
- G143R (p.Gly143Arg), gnomAD rs1351383040
- G143S (p.Gly143Ser), NCI-TCGA TCGA novel, REVEL 0.04, CADD 19.80, Variant assessed as somatic; moderate impact.
- Y145* (p.Tyr145Ter), NCI-TCGA Cosmic COSV9945, Variant assessed as somatic; high impact.
- Y145D (p.Tyr145Asp), rs1230840491, ClinGen CA408190517, ClinVar RCV001877237, TOPMed rs1230840491, REVEL 0.09, CADD 22.50, Uncertain significance, not provided
- Y145H (p.Tyr145His), TOPMed rs1230840491, gnomAD rs1230840491, REVEL 0.07, CADD 23.20, Uncertain significance
- F146L (p.Phe146Leu), gnomAD rs1332560904, REVEL 0.09, CADD 18.90, Likely benign
- F146S (p.Phe146Ser), TOPMed rs1304468847, gnomAD rs1304468847, REVEL 0.10, CADD 19.30
- K147N (p.Lys147Asn), rs377153001, ClinGen CA9758461, ClinVar RCV000522055, ESP rs377153001, REVEL 0.11, CADD 21.10, Uncertain significance, not provided
- K148E (p.Lys148Glu), TOPMed rs1982982948
- K148N (p.Lys148Asn), TOPMed rs1322714659, gnomAD rs1322714659, NCI-TCGA Cosmic COSV9945, REVEL 0.45, CADD 24.90, Variant assessed as somatic; moderate impact.
- K148R (p.Lys148Arg), rs112168905, ClinGen CA311229895, ClinVar RCV002639908, Ensembl rs112168905, AlphaMissense 0.31, MetaLR 0.60, Uncertain significance, not provided
- K148T (p.Lys148Thr), Ensembl rs112168905, Uncertain significance
- K149N (p.Lys149Asn), NCI-TCGA Cosmic COSV5409, Variant assessed as somatic; moderate impact.
- D153H (p.Asp153His), Ensembl rs1982981789
- K154Q (p.Lys154Gln), NCI-TCGA Cosmic COSV9945, Variant assessed as somatic; moderate impact.
- N156S (p.Asn156Ser), rs138019177, ClinGen CA9758457, ClinVar RCV000310894, ClinVar RCV000958036, REVEL 0.05, CADD 15.30, Benign, Kindler syndrome; not provided
- K157E (p.Lys157Glu), Ensembl rs1047738520
- K157Q (p.Lys157Gln), Ensembl rs1047738520
- P159T (p.Pro159Thr), gnomAD rs1982980699, REVEL 0.03, CADD 19.50
- I160L (p.Ile160Leu), 1000Genomes rs202137913, REVEL 0.12, CADD 0.02
- I160T (p.Ile160Thr), rs16991866, ClinGen CA9758456, ClinVar RCV000402388, ClinVar RCV001522483, REVEL 0.09, CADD 16.30, Benign, Kindler syndrome; not specified; not provided
- I161N (p.Ile161Asn), rs185559251, NCI-TCGA Cosmic COSV9945, 1000Genomes rs185559251, ExAC rs185559251, REVEL 0.02, CADD 15.90, Variant assessed as somatic; moderate impact.
- I161T (p.Ile161Thr), 1000Genomes rs185559251, ExAC rs185559251, TOPMed rs185559251, gnomAD rs185559251, REVEL 0.03, CADD 13.60, Uncertain significance, Inborn genetic diseases
- I161V (p.Ile161Val), gnomAD rs1173273684, REVEL 0.03, CADD 18.20
- E162G (p.Glu162Gly), ExAC rs771920901, gnomAD rs771920901, REVEL 0.12, CADD 23.20
- D163H (p.Asp163His), ExAC rs747844254, TOPMed rs747844254
- I164N (p.Ile164Asn), gnomAD rs1277865576, REVEL 0.07, CADD 22.50
- I164T (p.Ile164Thr), rs1277865576, ClinGen CA408190109, ClinVar RCV002950160, REVEL 0.06, CADD 21.30, Uncertain significance, Inborn genetic diseases
- S169I (p.Ser169Ile), gnomAD rs1346874528, REVEL 0.01, CADD 15.50
- S169N (p.Ser169Asn), gnomAD rs1346874528, REVEL 0.06, CADD 12.00
- S170Y (p.Ser170Tyr), NCI-TCGA Cosmic COSV5409, Variant assessed as somatic; moderate impact.
- P171A (p.Pro171Ala), gnomAD rs1280691705, REVEL 0.05, CADD 13.70
- T172A (p.Thr172Ala), gnomAD rs1227381733, REVEL 0.10, CADD 17.80
- A173T (p.Ala173Thr), NCI-TCGA Cosmic COSV9945, Variant assessed as somatic; moderate impact.
- G175A (p.Gly175Ala), rs755393121, ClinGen CA9758449, ClinVar RCV001138873, ClinVar RCV001856778, REVEL 0.21, CADD 14.90, Uncertain significance, Inborn genetic diseases; not provided; Kindler syndrome
- G175D (p.Gly175Asp), rs755393121, ClinGen CA9758450, ClinVar RCV001921066, ExAC rs755393121, REVEL 0.24, CADD 15.90, Uncertain significance, not provided
- G175V (p.Gly175Val), ExAC rs755393121, TOPMed rs755393121, gnomAD rs755393121, REVEL 0.20, CADD 20.20, Uncertain significance
- S176P (p.Ser176Pro), rs2514719816, ClinGen CA408189903, ClinVar RCV003856235, REVEL 0.06, CADD 14.30, Uncertain significance, not provided
- V178L (p.Val178Leu), TOPMed rs1173059236, REVEL 0.07, CADD 23.70
Public FERMT1 analysis runs
- FERMT1 analysis run — FERMT1 (968 variants) — completed 2026-08-22